Fresenius SE & Co KGaA (FRA:FRE) PT Set at €65.00 by Deutsche Bank

Deutsche Bank set a €65.00 ($75.58) target price on Fresenius SE & Co KGaA (FRA:FRE) in a research report report published on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Other equities research analysts also recently issued research reports about the stock. Berenberg Bank set a €70.95 ($82.50) target price on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Tuesday, July 30th. Goldman Sachs Group set a €53.00 ($61.63) price target on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a report on Tuesday, July 30th. JPMorgan Chase & Co. set a €57.90 ($67.33) price target on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a report on Wednesday. Barclays set a €52.00 ($60.47) price target on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a report on Thursday, July 18th. Finally, UBS Group set a €46.00 ($53.49) price target on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a report on Thursday, May 9th. Nine investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock currently has a consensus rating of Buy and a consensus target price of €58.60 ($68.14).

Shares of FRA:FRE opened at €44.71 ($51.98) on Wednesday. Fresenius SE & Co KGaA has a 52 week low of €60.16 ($69.95) and a 52 week high of €80.00 ($93.02). The firm has a 50 day moving average price of €46.65.

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Story: The components of the Stochastic Momentum Index

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.